HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.

Abstract
Tumorigenesis is a multistep process involving dysregulated cell growth and metastasis. Considerable evidence implicates a mitogenic action of estrogen in early ovarian carcinogenesis. In contrast, its influence in the metastatic cascade of ovarian tumor cells remains obscure. In the present study, we showed that 17beta-estradiol (E2) increased the metastatic potential of human epithelial ovarian cancer cell lines. E2 treatment led to clear morphological changes characteristic of epithelial-mesenchymal transition (EMT) and an enhanced cell migratory propensity. These morphological and functional alterations were associated with changes in the abundance of EMT-related genes. Upon E2 stimulation, expression and promoter activity of the epithelial marker E-cadherin were strikingly suppressed, whereas EMT-associated transcription factors, Snail and Slug, were significantly up-regulated. This up-regulation was attributed to the increase in gene transcription activated by E2. Depletion of endogenous Snail or Slug using small interfering RNA (siRNA) attenuated E2-mediated decrease in E-cadherin. In addition, E2-induced cell migration was also neutralized by the siRNAs, suggesting that both transcription factors are indispensable for the prometastatic actions of E2. More importantly, by using selective estrogen receptor (ER) agonists, forced expression, and siRNA approaches, we identified that E2 triggered the metastatic behaviors exclusively through an ERalpha-dependent pathway. We also showed that ERbeta had an opposing action on ERalpha because the presence of ERbeta completely inhibited the EMT and down-regulation of E-cadherin induced by ERalpha. Collectively, this study provides a compelling argument that estrogen can potentiate tumor progression by EMT induction and highlights the crucial role of ERalpha in ovarian tumorigenesis.
AuthorsSe-Hyung Park, Lydia W T Cheung, Alice S T Wong, Peter C K Leung
JournalMolecular endocrinology (Baltimore, Md.) (Mol Endocrinol) Vol. 22 Issue 9 Pg. 2085-98 (Sep 2008) ISSN: 0888-8809 [Print] United States
PMID18550773 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cadherins
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • RNA, Small Interfering
  • SNAI1 protein, human
  • Snail Family Transcription Factors
  • Transcription Factors
  • Estradiol
Topics
  • Base Sequence
  • Cadherins (genetics, metabolism)
  • Cell Line, Tumor
  • Cell Movement (drug effects)
  • Down-Regulation (drug effects)
  • Estradiol (pharmacology)
  • Estrogen Receptor alpha (metabolism)
  • Estrogen Receptor beta (metabolism)
  • Female
  • Humans
  • Ovarian Neoplasms (genetics, metabolism, physiopathology, secondary)
  • Promoter Regions, Genetic (drug effects)
  • RNA, Small Interfering (genetics)
  • Snail Family Transcription Factors
  • Transcription Factors (antagonists & inhibitors, genetics, metabolism)
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: